When this is done well, biomarkers accelerate decision-making, reduce uncertainty, and ultimately bring improved therapies to patients faster. When this is done poorly, however, biomarkers can add ...

The platform will be applied to identify potential biomarkers linked to treatment response prior to upcoming trial phases.

In a set of newly released presentations, officials from the US Food and Drug Administration (FDA) explain changes to the agency's biomarker qualification program and detail early opportunities for ...

Industry, FDA Discuss Benefits of Data Sharing in Biomarker Development Data sharing is critical to the validation of new biomarkers used in drug development, experts at the seventh annual Predictive ...

Every decision in drug development carries weight. The right biomarker insights can make those decisions more confident and data-driven. In this white paper, experts from AstraZeneca, Johnson & ...

This eBook is designed to deliver both strategic insight and practical guidance. It opens with a White Paper informed by ...

Drug development involves significant risk and expense. With average development costs topping $1 billion per approved medicine and stubbornly high failure rates, pharmaceutical leaders are ...

Protein biomarkers increasingly play a vital role in advancing health research, driving drug development, and improving clinical outcomes. The close connection between protein biomarkers and human ...

We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. 19 Table 1 summarizes the eligibility criteria. Study design Quantitative (interventional or ...

Researchers at The University of Texas MD Anderson Cancer Center and The University of Texas at Austin have identified ...